Gallbladder carcinoma associated with pancreatobiliary reflux

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 40

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

264

HTML

2001

Figures (1-1)

251

Tables (1-2)

201

Sum=2717

Oct 28, 2006 (publication date) through Jan 19, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Oct 28, 2006; 12(40): 6527-6530
Published online Oct 28, 2006. doi: 10.3748/wjg.v12.i40.6527

Table 2 Clinicopathological findings in patients with and without pancreaticobiliary maljunction

	non-PBM(n = 6)	PBM (n = 11)
Age (mean ± SD)	63.2 ± 7.2	54.1 ± 12
Female (number)	5/6 (83%)	9/11 (82%)
CBD-Amy (mean ± SD) IU/L	56 250 ± 19 246	102 686 ± 57 660
Cholecystolithiasis (number)	2/6 (33%)	4/11 (36%)
Length of the common channel (mean ± SD) mm	6.7 ± 2.2	23.6 ± 9.2
Gallbladder carcinoma (number)	3/6 (50%)	5/11 (46%)

PBM: Pancreaticobiliary maljunction; CBD-Amy: Amylase levels in the common bile duct; SD: Standard deviation.

Citation: Sai JK, Suyama M, Kubokawa Y, Nobukawa B. Gallbladder carcinoma associated with pancreatobiliary reflux. World J Gastroenterol 2006; 12(40): 6527-6530
URL: https://www.wjgnet.com/1007-9327/full/v12/i40/6527.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i40.6527